RECTOSIGMOID CANCER METASTATIC

RECTOSIGMOID CANCER METASTATIC was reported 37 times

These drug classes are most commonly taken by patients reporting RECTOSIGMOID CANCER METASTATIC:

# Drug Count
0 Epidermal Growth Factor Receptor Antagonist [EPC] 10
1 Nucleoside Metabolic Inhibitor [EPC] 10
2 Platinum-based Drug [EPC] 9
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 9
4 Corticosteroid [EPC] 6
5 Aldosterone Antagonist [EPC] 4
6 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4
7 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4
8 Leukocyte Growth Factor [EPC] 4
9 Loop Diuretic [EPC] 4
10 Thalidomide Analog [EPC] 4
11 Xanthine Oxidase Inhibitor [EPC] 4
12 Azole Antifungal [EPC] 3
13 Osmotic Laxative [EPC] 3
14 Integrin Receptor Antagonist [EPC] 2
15 Interleukin-12 Antagonist [EPC] 2
16 Interleukin-23 Antagonist [EPC] 2
17 Tumor Necrosis Factor Blocker [EPC] 2
18 Angiotensin 2 Receptor Blocker [EPC] 1
19 Arteriolar Vasodilator [EPC] 1
20 Bile Acid [EPC] 1
21 Calcineurin Inhibitor Immunosuppressant [EPC] 1
22 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
23 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
24 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
25 Janus Kinase Inhibitor [EPC] 1
26 Non-Standardized Chemical Allergen [EPC] 1
27 Non-Standardized Food Allergenic Extract [EPC] 1
28 Non-Standardized Plant Allergenic Extract [EPC] 1
29 Nonsteroidal Anti-inflammatory Drug [EPC] 1
30 Nucleoside Analog Antiviral [EPC] 1
31 Platelet Aggregation Inhibitor [EPC] 1
32 Serotonin-3 Receptor Antagonist [EPC] 1
33 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1
34 Thrombopoietin Receptor Agonist [EPC] 1
35 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1
36 alpha-Adrenergic Blocker [EPC] 1
37 beta-Adrenergic Blocker [EPC] 1